Insights & Resources

Texas life sciences in 2025 saw concentrated capital, declining innovation output and earlier‑stage clinical shifts shaping the ecosystem.

Get ahead of the curve by looking back at emerging trends in 2025 that are likely to impact health care valuation in 2026 and beyond. Download Weaver Insights now.

Texas life sciences saw record capital in Q4 2025, even as innovation, early-stage funding and late-phase clinical trials continued to decline.

Divorce misconceptions can complicate cases. Weaver shows how clear financial records help clarify assets, support fair outcomes and reduce conflict.

PET, CT and MRI volumes are accelerating. Learn what uneven imaging growth means for valuation and long-term planning.

Growth strategies in behavioral health are shifting. Learn how leaders can respond to industry headwinds and optimize performance effectively.

Explore Q3 2025 trends in Texas life sciences, from Series B collapse and pipeline bottlenecks to sector divergence and record late-stage capital.

After divorce, financial obligations continue. Forensic accountants help ensure compliance, transparency and long-term stability.

Forensic accountants provide expert testimony and litigation support, translating complex financial data into evidence that attorneys can use.

Costs are climbing across health care supply chains. Learn which areas face the most pressure and how to plan with confidence.

Forensic accountants value businesses and partnerships in divorce, separating personal from enterprise goodwill to support equitable outcomes.

Forensic accountants trace funds in divorce, clarifying commingling and financial history to support equitable outcomes.